SlideShare a Scribd company logo
Antibiotic Dosing During Renal Failure February 1, 2010 Sarah Nelson, Pharm.D. Critical Care Pharmacy Resident
Objectives ,[object Object],[object Object],[object Object],[object Object]
Kidney Disease ,[object Object],[object Object],[object Object],Wargo et al. Comparison of the Modification of Diet in Renal Disease and Cockroft-Gault  Equations for Antimicrobial Dosage Adjustments.  The Annals of Pharmacotherapy . 2006;40:1248-1253
Importance of Renal Function ,[object Object],[object Object],[object Object],[object Object],[object Object],Livornese et al. Use of antibacterial agents in renal failure. Infect Dis Clin N Am. 2004;18:551-579
Importance of Renal Function ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Renal Excretion http://www.unckidneycenter.org/images/glomerulus.jpg
Risk Factors/Markers of Renal Impairment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Calculating GFR ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Wargo et al. Comparison of the Modification of Diet in Renal Disease and Cockroft-Gault  Equations for Antimicrobial Dosage Adjustments.  The Annals of Pharmacotherapy . 2006;40:1248-1253
Calculating GFR ,[object Object],[object Object],[object Object],[object Object],[object Object],Moranville, M et al. Implications of using modification of diet in renal disease versus Cockroft-Gault  equations for renal dosing adjustments.  Am J Health-Syst Pharm.  2009;66:154-161
MDRD ,[object Object],[object Object],[object Object],[object Object],[object Object],Moranville, M et al. Implications of using modification of diet in renal disease versus Cockroft-Gault  equations for renal dosing adjustments.  Am J Health-Syst Pharm.  2009;66:154-161
MDRD ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Golik et al. Comparison of Dosing Recommendations for Antimicrobial Drugs Based on Two Methods for Assessing  Kidney Function: Cockroft-Gault and Modification of Diet in Renal Disease.  Pharmacotherapy.  2008;28(9):1125-1132
Cockroft-Gault ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Moranville, M et al. Implications of using modification of diet in renal disease versus Cockroft-Gault  equations for renal dosing adjustments.  Am J Health-Syst Pharm.  2009;66:154-161
Cockroft-Gault ,[object Object],[object Object],[object Object],[object Object],[object Object],Golik et al. Comparison of Dosing Recommendations for Antimicrobial Drugs Based on Two Methods for Assessing  Kidney Function: Cockroft-Gault and Modification of Diet in Renal Disease.  Pharmacotherapy.  2008;28(9):1125-1132
Weight Calculations ,[object Object],[object Object],[object Object]
Cockroft-Gault ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TIME OUT!! ,[object Object],[object Object],[object Object],[object Object],[object Object],SCr Weight Height 1.9 mg/dL 57 kg 5'3"
Pause for the Cause! ,[object Object],[object Object],[object Object],[object Object],[object Object],SCr Weight Height 2.85 mg/dL 86 kg 5‘10"
Which should I use? ,[object Object],[object Object],[object Object],[object Object],Wargo et al. Comparison of the Modification of Diet in Renal Disease and Cockroft-Gault  Equations for Antimicrobial Dosage Adjustments.  The Annals of Pharmacotherapy . 2006;40:1248-1253
Beware! ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Dosing in Renal Failure ,[object Object],[object Object],[object Object],[object Object]
Factors to Consider when Adjusting Dose ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Stages of Kidney Disease Adapted from the National Kidney Foundation Stage Description GFR (mL/min/1.73 m 2 ) 1 Kidney damage with normal GFR ≥ 90 2 Kidney damage with mild ↓ in GFR 60-89 3 Moderate ↓ GFR 30-59 4 Severe ↓ GFR 15-29 5 Kidney Failure <15 (or dialysis)
Dialysis ,[object Object],[object Object],[object Object],[object Object],[object Object],Rowland, Malcolm (1995).  Clinical Pharmacokinetics: Concepts and Applications . 3 rd  Ed. USA: Lippincott, Williams, and Wilkins. 448-453.
Dialysis ,[object Object],[object Object],[object Object],[object Object],[object Object],Rowland, Malcolm (1995).  Clinical Pharmacokinetics: Concepts and Applications . 3 rd  Ed. USA: Lippincott, Williams, and Wilkins. 448-453.
Continuous Dialysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Trotman et al. Antibiotic Dosing in Critically Ill Adult Patients Receiving Continuous  Renal Replacement Therapy.  CID . 2005;41:1159-1166
Adjusting Antimicrobials During Dialysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
References ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Example #1: Fluconazole ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Example #1: Fluconazole ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Example #1: Fluconazole ,[object Object],[object Object]
Example #2: Pip/Tazo ,[object Object],[object Object],1/19 1/20 1/22 1/23 Scr 0.9mg/dL 1.1mg/dL 1.24mg/dL 1.45mg/dL Weight Height UO 87 kg 5’4” 44 mL/hour
Example #2: Pip/Tazo ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Example #2: Pip/Tazo ,[object Object],[object Object],[object Object]
Example #3: Levofloxacin ,[object Object],[object Object],[object Object],[object Object],[object Object]
Example #3: Levofloxacin ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Example #3: Levofloxacin
Example #3: Levofloxacin ,[object Object]
Conclusions ,[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Anemia in ckd
Anemia in ckd Anemia in ckd
Anemia in ckd
Dr Ramesh Krishnan
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Membranous Nephropathy - Management Algorithm - Dr. Gawad
Membranous Nephropathy - Management Algorithm - Dr. GawadMembranous Nephropathy - Management Algorithm - Dr. Gawad
Membranous Nephropathy - Management Algorithm - Dr. Gawad
NephroTube - Dr.Gawad
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Hbv vaccination in ckd
Hbv vaccination in ckdHbv vaccination in ckd
Hbv vaccination in ckd
Mohamed Al-ameen
 
Ckd mbd
Ckd mbdCkd mbd
Ckd mbd
Harsh shaH
 
antibiotics induced renal failure
antibiotics induced renal failureantibiotics induced renal failure
antibiotics induced renal failure
Manoj Choudhary
 
Perioperative care of patients with kidney diseases prof (1). ahmed rabee
Perioperative care of patients with kidney diseases   prof (1). ahmed rabeePerioperative care of patients with kidney diseases   prof (1). ahmed rabee
Perioperative care of patients with kidney diseases prof (1). ahmed rabee
FarragBahbah
 
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. GawadLupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
NephroTube - Dr.Gawad
 
Anticoagulation in chronic kidney disease
Anticoagulation in chronic kidney diseaseAnticoagulation in chronic kidney disease
Anticoagulation in chronic kidney disease
FarragBahbah
 
Chronic Kidney Disease (CKD) - At a Glance - Dr. Gawad
Chronic Kidney Disease (CKD) - At a Glance - Dr. GawadChronic Kidney Disease (CKD) - At a Glance - Dr. Gawad
Chronic Kidney Disease (CKD) - At a Glance - Dr. Gawad
NephroTube - Dr.Gawad
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
NephroTube - Dr.Gawad
 
Hif ph inhibitors for anemia in ckd
Hif ph inhibitors for anemia in ckdHif ph inhibitors for anemia in ckd
Hif ph inhibitors for anemia in ckd
Harsh shaH
 
Membranous Nephropathy - Dr. Gawad
Membranous Nephropathy - Dr. GawadMembranous Nephropathy - Dr. Gawad
Membranous Nephropathy - Dr. Gawad
NephroTube - Dr.Gawad
 
Estimation of glomerular filtration rate
Estimation of glomerular filtration rateEstimation of glomerular filtration rate
Estimation of glomerular filtration rate
Arun Raj
 
Anemia in ckd
Anemia in ckdAnemia in ckd
Anemia in ckd
Philip Vaidyan
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
Manoj Prabhakar
 

What's hot (20)

Anemia in ckd
Anemia in ckd Anemia in ckd
Anemia in ckd
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Membranous Nephropathy - Management Algorithm - Dr. Gawad
Membranous Nephropathy - Management Algorithm - Dr. GawadMembranous Nephropathy - Management Algorithm - Dr. Gawad
Membranous Nephropathy - Management Algorithm - Dr. Gawad
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Management of ckd
Management of ckdManagement of ckd
Management of ckd
 
Hbv vaccination in ckd
Hbv vaccination in ckdHbv vaccination in ckd
Hbv vaccination in ckd
 
Ckd mbd
Ckd mbdCkd mbd
Ckd mbd
 
antibiotics induced renal failure
antibiotics induced renal failureantibiotics induced renal failure
antibiotics induced renal failure
 
Perioperative care of patients with kidney diseases prof (1). ahmed rabee
Perioperative care of patients with kidney diseases   prof (1). ahmed rabeePerioperative care of patients with kidney diseases   prof (1). ahmed rabee
Perioperative care of patients with kidney diseases prof (1). ahmed rabee
 
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. GawadLupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
 
Anticoagulation in chronic kidney disease
Anticoagulation in chronic kidney diseaseAnticoagulation in chronic kidney disease
Anticoagulation in chronic kidney disease
 
Chronic Kidney Disease (CKD) - At a Glance - Dr. Gawad
Chronic Kidney Disease (CKD) - At a Glance - Dr. GawadChronic Kidney Disease (CKD) - At a Glance - Dr. Gawad
Chronic Kidney Disease (CKD) - At a Glance - Dr. Gawad
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
 
Hif ph inhibitors for anemia in ckd
Hif ph inhibitors for anemia in ckdHif ph inhibitors for anemia in ckd
Hif ph inhibitors for anemia in ckd
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
Membranous Nephropathy - Dr. Gawad
Membranous Nephropathy - Dr. GawadMembranous Nephropathy - Dr. Gawad
Membranous Nephropathy - Dr. Gawad
 
Estimation of glomerular filtration rate
Estimation of glomerular filtration rateEstimation of glomerular filtration rate
Estimation of glomerular filtration rate
 
Anemia in ckd
Anemia in ckdAnemia in ckd
Anemia in ckd
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 

Viewers also liked

Part 2 - Aminoglycoside Vancomycin dosing
Part 2 - Aminoglycoside  Vancomycin dosingPart 2 - Aminoglycoside  Vancomycin dosing
Part 2 - Aminoglycoside Vancomycin dosingJeff Tollison
 
Dose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Dose Adjustment in Renal Failure ...Practical Approach for Clinical PharmacistsDose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Dose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Kareem El-Fass BPharm,PharmD
 
Dose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failureDose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failure
Pallavi Kurra
 
Drug use in hepatic and renal impairment
Drug use in hepatic and renal impairmentDrug use in hepatic and renal impairment
Drug use in hepatic and renal impairment
Akshil Mehta
 
Dosing of drugs in liver failure
Dosing of drugs in liver failureDosing of drugs in liver failure
Dosing of drugs in liver failure
YOUAN BI BENIET MARIUS
 
Vancomycin hydrochloride
Vancomycin hydrochlorideVancomycin hydrochloride
Vancomycin hydrochloride
Chris W
 
Drug dosing
Drug dosingDrug dosing
Drug dosing
Doha Rasheedy
 
Management Of The Morbidly Obese
Management Of The Morbidly ObeseManagement Of The Morbidly Obese
Management Of The Morbidly Obese
nels1937
 
Brief review of renal failure with chemotherapeutic agents
Brief review of renal failure with chemotherapeutic agentsBrief review of renal failure with chemotherapeutic agents
Brief review of renal failure with chemotherapeutic agents
Kasarla Dr Ramesh
 
Vancomycin
VancomycinVancomycin
Vancomycin
joelen6537
 
Drug profiles of Vancomycin, Prednisone and Salbutamol
Drug profiles of Vancomycin, Prednisone and SalbutamolDrug profiles of Vancomycin, Prednisone and Salbutamol
Drug profiles of Vancomycin, Prednisone and Salbutamol
Komal Haleem
 
Preventive and therapeutic strategies in critically ill patients with highly...
 Preventive and therapeutic strategies in critically ill patients with highly... Preventive and therapeutic strategies in critically ill patients with highly...
Preventive and therapeutic strategies in critically ill patients with highly...
Sergio Paul Silva Marin
 
Antimicrobials general I
Antimicrobials general IAntimicrobials general I
Van de graff ppt
Van de graff pptVan de graff ppt
Van de graff ppt
Kinjal Jain
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Dr. Armaan Singh
 
M1 accelerators
M1 acceleratorsM1 accelerators
M1 accelerators
Anuradha Verma
 
Accelerator
AcceleratorAccelerator
Accelerator
Aniruddha Maurya
 
Van de graaff
Van de graaffVan de graaff
Van de graaff
Abdul Wadood Khan
 

Viewers also liked (20)

Part 2 - Aminoglycoside Vancomycin dosing
Part 2 - Aminoglycoside  Vancomycin dosingPart 2 - Aminoglycoside  Vancomycin dosing
Part 2 - Aminoglycoside Vancomycin dosing
 
Dose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Dose Adjustment in Renal Failure ...Practical Approach for Clinical PharmacistsDose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Dose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
 
Dose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failureDose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failure
 
Drug use in hepatic and renal impairment
Drug use in hepatic and renal impairmentDrug use in hepatic and renal impairment
Drug use in hepatic and renal impairment
 
Dosing of drugs in liver failure
Dosing of drugs in liver failureDosing of drugs in liver failure
Dosing of drugs in liver failure
 
Vancomycin hydrochloride
Vancomycin hydrochlorideVancomycin hydrochloride
Vancomycin hydrochloride
 
Drug dosing
Drug dosingDrug dosing
Drug dosing
 
Chronic renal failure, surgical management
Chronic renal failure, surgical managementChronic renal failure, surgical management
Chronic renal failure, surgical management
 
Management Of The Morbidly Obese
Management Of The Morbidly ObeseManagement Of The Morbidly Obese
Management Of The Morbidly Obese
 
Brief review of renal failure with chemotherapeutic agents
Brief review of renal failure with chemotherapeutic agentsBrief review of renal failure with chemotherapeutic agents
Brief review of renal failure with chemotherapeutic agents
 
Vancomycin
VancomycinVancomycin
Vancomycin
 
Drug profiles of Vancomycin, Prednisone and Salbutamol
Drug profiles of Vancomycin, Prednisone and SalbutamolDrug profiles of Vancomycin, Prednisone and Salbutamol
Drug profiles of Vancomycin, Prednisone and Salbutamol
 
Preventive and therapeutic strategies in critically ill patients with highly...
 Preventive and therapeutic strategies in critically ill patients with highly... Preventive and therapeutic strategies in critically ill patients with highly...
Preventive and therapeutic strategies in critically ill patients with highly...
 
Antimicrobials general I
Antimicrobials general IAntimicrobials general I
Antimicrobials general I
 
Van de graff ppt
Van de graff pptVan de graff ppt
Van de graff ppt
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
M1 accelerators
M1 acceleratorsM1 accelerators
M1 accelerators
 
Accelerator
AcceleratorAccelerator
Accelerator
 
kamal project ppt
kamal project pptkamal project ppt
kamal project ppt
 
Van de graaff
Van de graaffVan de graaff
Van de graaff
 

Similar to Antibiotic Dosing During Renal Failure

Creatinine clearance: When Does It Matter?
Creatinine clearance: When Does It Matter?Creatinine clearance: When Does It Matter?
Creatinine clearance: When Does It Matter?
PASaskatchewan
 
Drug dosage adjustment using renal estimation equations. A review of the lite...
Drug dosage adjustment using renal estimation equations. A review of the lite...Drug dosage adjustment using renal estimation equations. A review of the lite...
Drug dosage adjustment using renal estimation equations. A review of the lite...Greenberg, Eric
 
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease. Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Kevin John
 
Journal club: Is Early Dialysis Better?
Journal club: Is Early Dialysis Better?Journal club: Is Early Dialysis Better?
Journal club: Is Early Dialysis Better?
Hofstra Northwell School of Medicine
 
38 use of drugs in children with impaired renal function
38 use of drugs in children with impaired renal function38 use of drugs in children with impaired renal function
38 use of drugs in children with impaired renal functionDang Thanh Tuan
 
Dosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptxDosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptx
SaishDalvi
 
35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokinetics35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokineticsDang Thanh Tuan
 
Initiation And Incremental Dialysis
Initiation And Incremental DialysisInitiation And Incremental Dialysis
Initiation And Incremental Dialysis
edwinchowyw
 
Voclosporin journal club
Voclosporin journal clubVoclosporin journal club
Voclosporin journal club
Dr. Prem Mohan Jha
 
Newer Chemotherapy agents and renal toxicity
Newer Chemotherapy agents and renal toxicityNewer Chemotherapy agents and renal toxicity
Newer Chemotherapy agents and renal toxicitykdj200
 
Transporters and Their Role in Drug Interactions
Transporters and Their Role in Drug InteractionsTransporters and Their Role in Drug Interactions
Transporters and Their Role in Drug Interactionsshabeel pn
 
Renal-prescribing-NMP-forum-July-2019.pdf
Renal-prescribing-NMP-forum-July-2019.pdfRenal-prescribing-NMP-forum-July-2019.pdf
Renal-prescribing-NMP-forum-July-2019.pdf
OctavioGamez1
 
17 february lupus nephritis prof ashraf fouda
17 february lupus nephritis prof ashraf fouda17 february lupus nephritis prof ashraf fouda
17 february lupus nephritis prof ashraf fouda
FarragBahbah
 
Pharmacokinetics in the Critically Ill
Pharmacokinetics in the Critically IllPharmacokinetics in the Critically Ill
Pharmacokinetics in the Critically Ill
SMACC Conference
 
Euvas trials
Euvas trialsEuvas trials
Euvas trials
Dr. Prem Mohan Jha
 
HepaticDosageAdjustment.pdf
HepaticDosageAdjustment.pdfHepaticDosageAdjustment.pdf
HepaticDosageAdjustment.pdf
Helena949653
 
SLE: present guidelines and consensus
SLE: present guidelines and consensusSLE: present guidelines and consensus
SLE: present guidelines and consensusVishal Golay
 

Similar to Antibiotic Dosing During Renal Failure (20)

Creatinine clearance: When Does It Matter?
Creatinine clearance: When Does It Matter?Creatinine clearance: When Does It Matter?
Creatinine clearance: When Does It Matter?
 
Drug dosage adjustment using renal estimation equations. A review of the lite...
Drug dosage adjustment using renal estimation equations. A review of the lite...Drug dosage adjustment using renal estimation equations. A review of the lite...
Drug dosage adjustment using renal estimation equations. A review of the lite...
 
E gfr for web
E gfr for webE gfr for web
E gfr for web
 
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease. Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
 
Journal club: Is Early Dialysis Better?
Journal club: Is Early Dialysis Better?Journal club: Is Early Dialysis Better?
Journal club: Is Early Dialysis Better?
 
38 use of drugs in children with impaired renal function
38 use of drugs in children with impaired renal function38 use of drugs in children with impaired renal function
38 use of drugs in children with impaired renal function
 
Dosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptxDosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptx
 
35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokinetics35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokinetics
 
Initiation And Incremental Dialysis
Initiation And Incremental DialysisInitiation And Incremental Dialysis
Initiation And Incremental Dialysis
 
Voclosporin journal club
Voclosporin journal clubVoclosporin journal club
Voclosporin journal club
 
Newer Chemotherapy agents and renal toxicity
Newer Chemotherapy agents and renal toxicityNewer Chemotherapy agents and renal toxicity
Newer Chemotherapy agents and renal toxicity
 
Transporters and Their Role in Drug Interactions
Transporters and Their Role in Drug InteractionsTransporters and Their Role in Drug Interactions
Transporters and Their Role in Drug Interactions
 
Renal-prescribing-NMP-forum-July-2019.pdf
Renal-prescribing-NMP-forum-July-2019.pdfRenal-prescribing-NMP-forum-July-2019.pdf
Renal-prescribing-NMP-forum-July-2019.pdf
 
17 february lupus nephritis prof ashraf fouda
17 february lupus nephritis prof ashraf fouda17 february lupus nephritis prof ashraf fouda
17 february lupus nephritis prof ashraf fouda
 
Pharmacokinetics in the Critically Ill
Pharmacokinetics in the Critically IllPharmacokinetics in the Critically Ill
Pharmacokinetics in the Critically Ill
 
Ckd
CkdCkd
Ckd
 
Euvas trials
Euvas trialsEuvas trials
Euvas trials
 
HepaticDosageAdjustment.pdf
HepaticDosageAdjustment.pdfHepaticDosageAdjustment.pdf
HepaticDosageAdjustment.pdf
 
SLE: present guidelines and consensus
SLE: present guidelines and consensusSLE: present guidelines and consensus
SLE: present guidelines and consensus
 
2010 uptodate adequacy dp
2010 uptodate adequacy dp2010 uptodate adequacy dp
2010 uptodate adequacy dp
 

Antibiotic Dosing During Renal Failure